Form 8K Biofrontera Inc For: 16 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biofrontera Inc (BFRI)
Biofrontera Inc stock price live, this page displays NASDAQ BFRI stock exchange data. View the BFRI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biofrontera Inc real time stock price chart below.
What Is the Biofrontera Inc Stock Price Today?
The Biofrontera Inc stock price today is 1.0400.
What Is the Stock Symbol for Biofrontera Inc?
The stock symbol for Biofrontera Inc is ""BFRI.""
What Stock Exchange Does Biofrontera Inc Trade On?
Biofrontera Inc is listed and trades on the NASDAQ stock exchange.
Is Biofrontera Inc a Good Stock to Buy?
Determining whether Biofrontera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BFRI quote. (ISIN: US09077D2099)
What Is the Biofrontera Inc Stock Price Today?
The Biofrontera Inc stock price today is 1.0400.
What Is the Stock Symbol for Biofrontera Inc?
The stock symbol for Biofrontera Inc is ""BFRI.""
What Stock Exchange Does Biofrontera Inc Trade On?
Biofrontera Inc is listed and trades on the NASDAQ stock exchange.
Is Biofrontera Inc a Good Stock to Buy?
Determining whether Biofrontera Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BFRI quote. (ISIN: US09077D2099)
NASDAQ
Currency in USD
1.0400
-0.0400(-3.70%)
Closed·
Fair Value
An estimate of a Biofrontera's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0200
1.1140
52 wk Range
0.5360
2.2200
BFRI Scorecard
Full Analysis
Quickly burning through cash
BFRI is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Biofrontera's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.02001.1140
52 wk Range
0.53602.2200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BFRI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Biofrontera's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
6.3750
Upside
+512.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low revenue valuation multiple
- Form 8K Biofrontera Inc For: 1 July
- Investing.com
- Form 8K Biofrontera Inc For: 16 July
- Investing.com
- Form 8K Biofrontera Inc For: 1 July
- Investing.com
- Form 8K Biofrontera Inc For: 30 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Biofrontera Inc Company Profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Biofrontera Inc Earnings Call Summary for Q1/2025
- Revenue up 9% YoY to $8.6M; net loss improved to $4.2M from $10.4M; stock down 7.6% post-earnings
- New Ameluz formulation patent granted, extending protection to 2043; focus on expanding treatment indications
- Cash and equivalents at $1.8M, down from $5.9M EOY 2024; inventory stable at $6.5M
- FDA submissions planned for H2 2025 for Ameluz body treatment and superficial basal cell carcinoma
- CEO expects record 2025 revenues without cost increases; cash constraints and FDA approvals remain key challenges
Last Updated: 16/05/2025, 15:48
Read Full TranscriptCompare BFRI to Peers and Sector
Metrics to compare | BFRI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBFRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.9x | −1.3x | −0.5x | |
PEG Ratio | −0.01 | 0.00 | 0.00 | |
Price/Book | 20.9x | 0.3x | 2.6x | |
Price / LTM Sales | 0.3x | 1.7x | 3.3x | |
Upside (Analyst Target) | - | 135.7% | 45.4% | |
Fair Value Upside | Unlock | 10.7% | 7.7% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.3750
(+512.98% Upside)
Earnings
Latest Release
May 15, 2025
EPS / Forecast
-0.47 / -0.19
Revenue / Forecast
8.59M / --
People Also Watch
FAQ
What Stock Exchange Does Biofrontera Trade On?
Biofrontera is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Biofrontera?
The stock symbol for Biofrontera is "BFRI."
What Is the Biofrontera Market Cap?
As of today, Biofrontera market cap is 9.82M.
What Is Biofrontera's Earnings Per Share (TTM)?
The Biofrontera EPS (TTM) is -1.69.
From a Technical Analysis Perspective, Is BFRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Biofrontera Stock Split?
Biofrontera has split 1 times.
How Many Employees Does Biofrontera Have?
Biofrontera has 93 employees.
What is the current trading status of Biofrontera (BFRI)?
As of 03 Aug 2025, Biofrontera (BFRI) is trading at a price of 1.04, with a previous close of 1.08. The stock has fluctuated within a day range of 1.02 to 1.11, while its 52-week range spans from 0.54 to 2.22.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.